TERESITA DEVERA: Open Payments
NPI 1386985216 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 30 payments from 17 companies in 2025. Trend: 2023 $362 · 2024 $997 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $474 |
| Medtronic, Inc. | 3 | $96 |
| UCB, Inc. | 3 | $57 |
| ARGENX US, INC. | 3 | $53 |
| Boston Scientific Corporation | 1 | $47 |
| BIOTRONIK NRO, Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $35 |
| Saluda Medical Americas, Inc. | 1 | $25 |
| Biogen, Inc. | 1 | $24 |
Products named: INFINITY, ACCURIAN, General - DBS, Prospera, Briviact, VYVGART HYTRULO, Evoke, TYSABRI.
Industry payments across PA — which companies pay providers there.
